234 related articles for article (PubMed ID: 32987177)
1. Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
Skrip L; Derra K; Kaboré M; Noori N; Gansané A; Valéa I; Tinto H; Brice BW; Gordon MV; Hagedorn B; Hien H; Althouse BM; Wenger EA; Ouédraogo AL
Int J Infect Dis; 2020 Dec; 101():194-200. PubMed ID: 32987177
[TBL] [Abstract][Full Text] [Related]
2. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries.
Nachega JB; Sam-Agudu NA; Machekano RN; Rabie H; van der Zalm MM; Redfern A; Dramowski A; O'Connell N; Pipo MT; Tshilanda MB; Byamungu LN; Masekela R; Jeena PM; Pillay A; Gachuno OW; Kinuthia J; Ishoso DK; Amoako E; Agyare E; Agbeno EK; Martyn-Dickens C; Sylverken J; Enimil A; Jibril AM; Abdullahi AM; Amadi O; Umar UM; Sigwadhi LN; Hermans MP; Otokoye JO; Mbala-Kingebeni P; Muyembe-Tamfum JJ; Zumla A; Sewankambo NK; Aanyu HT; Musoke P; Suleman F; Adejumo P; Noormahomed EV; Deckelbaum RJ; Fowler MG; Tshilolo L; Smith G; Mills EJ; Umar LW; Siedner MJ; Kruger M; Rosenthal PJ; Mellors JW; Mofenson LM;
JAMA Pediatr; 2022 Mar; 176(3):e216436. PubMed ID: 35044430
[TBL] [Abstract][Full Text] [Related]
5. [Factors associated with the occurrence of acute respiratory distress and death in patients with COVID-19 in Burkina Faso].
Ouédraogo AR; Bougma G; Baguiya A; Sawadogo A; Kaboré PR; Minougou CJ; Diendéré A; Maiga S; Agbaholou CR; Hema A; Sondo A; Ouédraogo G; Sanou A; Ouedraogo M
Rev Mal Respir; 2021 Mar; 38(3):240-248. PubMed ID: 33589360
[TBL] [Abstract][Full Text] [Related]
6. Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Kaboré NF; Ouédraogo S; Mamguem AK; Traoré IT; Kania D; Badolo H; Sanou G; Koné A; Yara M; Kagoné T; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendéré AE; Ouédraogo B; Billa O; Paradis G; Dabakuyo-Yonli TS; Tinto H
BMC Infect Dis; 2023 Jun; 23(1):394. PubMed ID: 37308819
[TBL] [Abstract][Full Text] [Related]
7. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.
Traoré IT; Ouedraogo S; Kania D; Kaboré FN; Konaté B; Médah R; Badolo H; de Rekeneire N; Kamga AM; Poda A; Diendere AE; Ouédraogo B; Ouédraogo E; Billa O; Tinto H; Dabakuyo-Yonli TS
BMC Infect Dis; 2021 Sep; 21(1):896. PubMed ID: 34479501
[TBL] [Abstract][Full Text] [Related]
9. Seeding COVID-19 across Sub-Saharan Africa: An Analysis of Reported Importation Events across 49 Countries.
Skrip LA; Selvaraj P; Hagedorn B; Ouédraogo AL; Noori N; Orcutt A; Mistry D; Bedson J; Hébert-Dufresne L; Scarpino SV; Althouse BM
Am J Trop Med Hyg; 2021 Mar; 104(5):1694-1702. PubMed ID: 33684067
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Preventive Practices, Psychological Distress, and Reported Barriers to Healthcare Access during the Pandemic among Adult Community Members in Sub-Saharan Africa: A Phone Survey.
Assefa N; Abdullahi YY; Hemler EC; Lankoande B; Madzorera I; Wang D; Ismail A; Chukwu A; Workneh F; Mapendo F; Millogo O; Abubakari SW; Febir LG; Lyatuu I; Dianou K; Baernighausen T; Soura A; Asante KP; Smith E; Vuai S; Worku A; Killewo J; Mwanyika-Sando M; Berhane Y; Sie A; Tajudeen R; Oduola A; Fawzi WW
Am J Trop Med Hyg; 2023 Jan; 108(1):124-136. PubMed ID: 36509058
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
13. The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Ouedraogo S; Traoré IT; Kania D; Kaboré NF; Mamguem Kamga A; Badolo H; Yara M; Sanou G; Koné A; Kagoné ST; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendere AE; Ouédraogo B; Billa O; Paradis G; Tinto H; Dabakuyo-Yonli TS
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13216. PubMed ID: 38019697
[TBL] [Abstract][Full Text] [Related]
14. Impact evaluation of the free maternal healthcare policy on the risk of neonatal and infant deaths in four sub-Saharan African countries: a quasi-experimental design with propensity score Kernel matching and difference in differences analysis.
Dwomoh D; Agyabeng K; Agbeshie K; Incoom G; Nortey P; Yawson A; Bosomprah S
BMJ Open; 2020 May; 10(5):e033356. PubMed ID: 32414818
[TBL] [Abstract][Full Text] [Related]
15. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
16. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for preterm delivery in Burkina Faso (west Africa).
Prazuck T; Tall F; Roisin AJ; Konfe S; Cot M; Lafaix C
Int J Epidemiol; 1993 Jun; 22(3):489-94. PubMed ID: 8359966
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
